UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 160

Sortiert nach

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients

PloS one, 2019-04, Vol.14 (4), p.e0215443-e0215443

2019

Link zum Volltext

Verfügbarkeit prüfen

Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry

Viruses, 2021-06, Vol.13 (7), p.1246

2021

Link zum Volltext

Verfügbarkeit prüfen

Predictors of chronic COVID-19 symptoms in a community-based cohort of adults

PloS one, 2022-08, Vol.17 (8), p.e0271310-e0271310

2022

Link zum Volltext

Verfügbarkeit prüfen

Roles of HIV-1 Env variable regions in viral neutralization and vaccine development

Current HIV research, 2007-11, Vol.5 (6), p.542

Pinter, Abraham

2007

Link zum Volltext

Verfügbarkeit prüfen

CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro

Frontiers in immunology, 2021-07, Vol.12, p.652223-652223

2021

Link zum Volltext

Verfügbarkeit prüfen

Insights into next generation sequencing guided antibody selection strategies

Scientific reports, 2023-10, Vol.13 (1), p.18370-18370, Article 18370

2023

Link zum Volltext

Verfügbarkeit prüfen

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

PloS one, 2017-07, Vol.12 (7), p.e0180720-e0180720

2017

Link zum Volltext

Verfügbarkeit prüfen

Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2

BMC medicine, 2022-01, Vol.20 (1), p.32-32, Article 32

2022

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Insights into next generation sequencing guided antibody selection strategies

Scientific reports, 2023-12, Vol.13 (1), p.22616-22616, Article 22616

2023

Link zum Volltext

Verfügbarkeit prüfen

Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop

Journal of Virology, 2011-04, Vol.85 (7), p.3128-3141

2011

Link zum Volltext

Verfügbarkeit prüfen

Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis

PloS one, 2022-09, Vol.17 (9), p.e0274415

2022

Link zum Volltext

Verfügbarkeit prüfen

Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis

PloS one, 2022-09, Vol.17 (9), p.e0274415-e0274415

2022

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies

Nature communications, 2022-04, Vol.13 (1), p.1-1, Article 2097

2022

Link zum Volltext

Verfügbarkeit prüfen

A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies

Nature communications, 2022-01, Vol.13 (1), p.1-12, Article 462

2022

Link zum Volltext

Verfügbarkeit prüfen

Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms

Viruses, 2021-05, Vol.13 (6), p.953

2021

Link zum Volltext

Verfügbarkeit prüfen

Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways

PLoS pathogens, 2009-09, Vol.5 (9), p.e1000594-e1000594

2009

Link zum Volltext

Verfügbarkeit prüfen

Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy

PloS one, 2017-07, Vol.12 (7), p.e0180245-e0180245

2017

Link zum Volltext

Verfügbarkeit prüfen

The V1/V2 Domain of gp120 Is a Global Regulator of the Sensitivity of Primary Human Immunodeficiency Virus Type 1 Isolates to Neutralization by Antibodies Commonly Induced upon Infection

Journal of Virology, 2004-05, Vol.78 (10), p.5205-5215

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein

PLoS computational biology, 2016-10, Vol.12 (10), p.e1005094-e1005094

2016

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 Seroprevalence and Symptom Onset in Culturally Linked Orthodox Jewish Communities Across Multiple Regions in the United States

JAMA network open, 2021-03, Vol.4 (3), p.e212816-e212816

2021

Link zum Volltext

Verfügbarkeit prüfen

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s

Frontiers in immunology, 2022-01, Vol.12, p.787603-787603

2022

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Insights into next generation sequencing guided antibody selection strategies

Scientific reports, 2024-02, Vol.14 (1), p.3090-3090

2024

Link zum Volltext

Verfügbarkeit prüfen

Computational prediction of neutralization epitopes targeted by human anti-V3 HIV monoclonal antibodies

PloS one, 2014-02, Vol.9 (2), p.e89987-e89987

2014

Link zum Volltext

Verfügbarkeit prüfen

Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1

Molecular immunology, 2009-02, Vol.46 (5), p.917-926

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 160

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(116)
Life Sciences & Biomedicine
(98)
Humans
(74)
Virology
(67)
Animals
(44)
Hiv-1 - Immunology
(44)
Hiv Envelope Protein Gp120 - Immunology
(43)
Human Immunodeficiency Virus 1
(40)
Immunology
(40)
Biological And Medical Sciences
(38)
Microbiology
(36)
Amino Acid Sequence
(32)
Fundamental And Applied Biological Sciences. Psychology
(31)
Molecular Sequence Data
(31)
Infectious Diseases
(30)
Aids/hiv
(27)
Neutralization Tests
(27)
Antibodies, Monoclonal - Immunology
(26)
Epitopes - Immunology
(24)
Hiv
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Virology
(28)
Virology
(21)
Plos One
(14)
Aids Research And Human Retroviruses
(11)
Nature Communications
(5)
Scientific Reports
(5)
The Journal Of Immunology
(5)
The New England Journal Of Medicine
(5)
Pediatric Research
(4)
Plos Pathogens
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients

Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry

Predictors of chronic COVID-19 symptoms in a community-based cohort of adults

Roles of HIV-1 Env variable regions in viral neutralization and vaccine development

CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro

Insights into next generation sequencing guided antibody selection strategies

V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2

Author Correction: Insights into next generation sequencing guided antibody selection strategies

Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop

Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis

Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis

Author Correction: A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies

A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies

Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms

Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways

Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy

The V1/V2 Domain of gp120 Is a Global Regulator of the Sensitivity of Primary Human Immunodeficiency Virus Type 1 Isolates to Neutralization by Antibodies Commonly Induced upon Infection

Effect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein

DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques

SARS-CoV-2 Seroprevalence and Symptom Onset in Culturally Linked Orthodox Jewish Communities Across Multiple Regions in the United States

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s

Author Correction: Insights into next generation sequencing guided antibody selection strategies

Computational prediction of neutralization epitopes targeted by human anti-V3 HIV monoclonal antibodies

Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1

Suchergebnisse filtern